ESMO 2026 Presidential Symposia: From Trial Results to Clinical Implications
Phase II Trial Shows Promising Pathologic Responses With Neoadjuvant Nivolumab and Chemotherapy in Salivary Gland Cancer
OncoDaily and Natera Present “Seismic Shift: Innovations in MRD Testing and Pathology”
A National Multidisciplinary BC Course Has Trained 180 Clinicians Across Mongolia - UICC
ESMO 2026: What’s New in Melanoma Immunotherapy?
High CA-125 Levels: Causes, Normal Range and Cancer Risk
Sara Tolaney: Breast Cancer Insights From ESMO 2026
NEOASIS at ESMO 2026: Neoadjuvant Botensilimab Plus Balstilimab in dMMR Colorectal Cancer
The Cancer Metabolism and Signaling in the Tumor Microenvironment 2027 symposium, organized by the New York Academy of Sciences (NYAS), will take place on March 24, 2027, at 550 First […]
